Transcutaneous Bilirubinometry in Neonates
Accuracy of Transcutaneous Bilirubin Determinations in Neonates: The Effect of Gestational Age, Time and Site of Measurement
1 other identifier
observational
255
1 country
1
Brief Summary
Objective: To assess the accuracy of transcutaneous bilirubin (TcB) measurements in neonates, in relation to gestational age (GA), time (postnatal hour) and site (forehead, sternum, knee) of measurements. Hypothesis: Using (or combining) different sites for TcB determination might improve the accuracy of TcB in relation to the time of measurement and the GA of the neonate. Methods: The study will include neonates \>32 weeks' gestation cared for in the well-baby nursery and NICU of the University Hospital of Patras, from September to December 2011. Data such as sex, gestational age, gestation and perinatal information, mother's and infant's ABO group and Rh, G6PD deficiency, Coombs test, type of delivery and complications, birthweight, postnatal medications and interventions, type and volume of feeding, and extension of jaundice, will be collected. TcB measurements will be performed using the BiliCheck bilirubinometer (according to the standard protocol) at 3 different sites: forehead, sternum and knee. Total serum bilirubin (TSB) values will be obtained using the heel stick technique, and measurements will be performed by a direct spectrophotometric device (Unistat bilirubinometer, Richert, Depew, NY). The accuracy of the device has been validated previously. TSB measurements will be performed within 5 minutes of the TcB measurements. At each occasion TcB measurements (3), the corresponding TSB value, the time of measurement (postnatal hours), and the actual weight will be noted. Statistics: The agreement between TcB and TSB values will be assessed using the Bland-Altman % method. The independent and joint effects of GA and time of measurement on bias will be evaluated by multivariate regression analysis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2011
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2011
CompletedFirst Submitted
Initial submission to the registry
August 22, 2011
CompletedFirst Posted
Study publicly available on registry
August 24, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2012
CompletedJanuary 24, 2012
January 1, 2012
5 months
August 22, 2011
January 22, 2012
Conditions
Outcome Measures
Primary Outcomes (1)
Accuracy characteristics of TcB as compared to TSB
TcB measurements performed at 3 different sites (forehead, sternum, knee)will be compared with the corresponding TSB value. The agreement between TcB and TSB values will be assessed using the Bland-Altman % method. The effect of gestational age and time of measurement (postnatal hour)on TcB bias will be explored by multivariate regression analysis.
Tcb vs TSB measurements at any time from birth to 120 postnatal hours
Eligibility Criteria
Term and preterm neonates from birth to 120 postnatal hours
You may qualify if:
- Born at the University Hospital of Patras
- GA \>32 weeks
- Parental consent to participate
You may not qualify if:
- Under phototherapy
- Congenital infections
- Chromosomal abnormalities
- Congenital abnormalities
- Hepatic dysfunction
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Neonatal Intensive Care Unit, University Hospital of Patras
Pátrai, 26504, Greece
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sotirios Fouzas, MD
Neonatal Intensive Care Unit, University Hospital of Patras
- STUDY DIRECTOR
Anastasia Varvarigou, Prof
Neonatal Intensive Care Unit, University Hospital of Patras
- PRINCIPAL INVESTIGATOR
Eugenia Panagiotopoulou, MD
Neonatal Intensive Care Unit, University Hospital of Patras
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Pediatrician, Neonatal Intensive Care Unit, University Hospital of Patras
Study Record Dates
First Submitted
August 22, 2011
First Posted
August 24, 2011
Study Start
August 1, 2011
Primary Completion
January 1, 2012
Study Completion
January 1, 2012
Last Updated
January 24, 2012
Record last verified: 2012-01